Concepts (73)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Image Interpretation, Computer-Assisted | 7 | 2018 | 107 | 2.240 |
Why?
|
| Ovarian Neoplasms | 6 | 2024 | 566 | 2.160 |
Why?
|
| Microscopy | 3 | 2024 | 38 | 2.070 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2024 | 247 | 2.040 |
Why?
|
| Mammography | 7 | 2022 | 79 | 1.720 |
Why?
|
| Breast Neoplasms | 6 | 2022 | 446 | 1.570 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 5 | 2019 | 58 | 1.490 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2020 | 467 | 1.280 |
Why?
|
| Lenses | 2 | 2022 | 12 | 1.180 |
Why?
|
| Lighting | 1 | 2024 | 9 | 0.930 |
Why?
|
| Metaphase | 2 | 2014 | 29 | 0.880 |
Why?
|
| Neoadjuvant Therapy | 1 | 2024 | 69 | 0.870 |
Why?
|
| High-Throughput Screening Assays | 2 | 2014 | 36 | 0.870 |
Why?
|
| Algorithms | 7 | 2022 | 422 | 0.770 |
Why?
|
| Machine Learning | 3 | 2022 | 81 | 0.700 |
Why?
|
| Chromosomes | 2 | 2022 | 59 | 0.650 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2020 | 285 | 0.580 |
Why?
|
| Humans | 20 | 2024 | 27139 | 0.540 |
Why?
|
| ROC Curve | 5 | 2022 | 137 | 0.490 |
Why?
|
| Retrospective Studies | 6 | 2024 | 2464 | 0.470 |
Why?
|
| Pattern Recognition, Automated | 1 | 2014 | 32 | 0.470 |
Why?
|
| Female | 13 | 2024 | 14631 | 0.460 |
Why?
|
| Fourier Analysis | 2 | 2024 | 31 | 0.430 |
Why?
|
| Karyotyping | 1 | 2013 | 24 | 0.420 |
Why?
|
| Chromosomes, Human | 1 | 2013 | 31 | 0.410 |
Why?
|
| Cytogenetic Analysis | 1 | 2012 | 8 | 0.410 |
Why?
|
| Chromosome Mapping | 1 | 2012 | 131 | 0.400 |
Why?
|
| Artifacts | 1 | 2012 | 49 | 0.390 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 163 | 0.380 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2022 | 57 | 0.360 |
Why?
|
| Area Under Curve | 4 | 2022 | 94 | 0.350 |
Why?
|
| Predictive Value of Tests | 2 | 2024 | 472 | 0.300 |
Why?
|
| Databases, Factual | 2 | 2019 | 253 | 0.290 |
Why?
|
| Abdominal Fat | 2 | 2017 | 17 | 0.270 |
Why?
|
| Color | 1 | 2024 | 22 | 0.230 |
Why?
|
| Aged | 4 | 2018 | 5222 | 0.230 |
Why?
|
| Support Vector Machine | 2 | 2022 | 21 | 0.210 |
Why?
|
| Breast Density | 2 | 2019 | 10 | 0.200 |
Why?
|
| Supervised Machine Learning | 1 | 2022 | 8 | 0.200 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 64 | 0.190 |
Why?
|
| Radiography, Thoracic | 1 | 2020 | 12 | 0.180 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2020 | 28 | 0.180 |
Why?
|
| Breast | 2 | 2018 | 54 | 0.180 |
Why?
|
| Lymphatic Metastasis | 1 | 2020 | 119 | 0.170 |
Why?
|
| Lymph Nodes | 1 | 2020 | 97 | 0.170 |
Why?
|
| Disease-Free Survival | 2 | 2016 | 225 | 0.160 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 24 | 0.150 |
Why?
|
| Cluster Analysis | 1 | 2018 | 119 | 0.150 |
Why?
|
| Middle Aged | 3 | 2018 | 6906 | 0.140 |
Why?
|
| Breast Diseases | 1 | 2015 | 7 | 0.130 |
Why?
|
| Risk Assessment | 1 | 2018 | 594 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 1939 | 0.120 |
Why?
|
| Automation, Laboratory | 1 | 2013 | 4 | 0.110 |
Why?
|
| Workflow | 1 | 2013 | 25 | 0.100 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 41 | 0.100 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 36 | 0.100 |
Why?
|
| Image Enhancement | 1 | 2012 | 58 | 0.100 |
Why?
|
| Equipment Design | 1 | 2012 | 211 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 509 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 657 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 751 | 0.080 |
Why?
|
| Time Factors | 1 | 2013 | 1572 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2016 | 191 | 0.060 |
Why?
|
| Subcutaneous Fat | 1 | 2017 | 16 | 0.040 |
Why?
|
| Intra-Abdominal Fat | 1 | 2017 | 20 | 0.030 |
Why?
|
| Abdomen | 1 | 2017 | 41 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2016 | 15 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 279 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2015 | 21 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 398 | 0.030 |
Why?
|
| Young Adult | 1 | 2018 | 2628 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 2286 | 0.020 |
Why?
|
| Adult | 1 | 2018 | 7496 | 0.020 |
Why?
|